Evidence map›Paper›PMID 18801933›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2008

Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1.

Noriaki Shimizu, Noritada Yoshikawa, Tadashi Wada, Hiroshi Handa, Motoaki Sano, Keiichi Fukuda, Makoto Suematsu, Takashi Sawai, Chikao Morimoto, Hirotoshi Tanaka

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Transcriptional regulation of FoxO3 gene by glucocorticoids in murine myotubes.American journal of physiology. Endocrinology and metabolism · 2016
    Article
  2. Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Noriaki ShimizuDivision of Clinical Immunology, Advanced Clinical Research Center, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Noritada Yoshikawa
Tadashi Wada
Hiroshi Handa
Motoaki Sano
Keiichi Fukuda
Makoto Suematsu
Takashi Sawai
Chikao Morimoto
Hirotoshi Tanaka
The University of Tokyo · JPKeio University · JPIwate Medical University · JPResearch Institute for Bioscience and Biotechnology · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiological and pharmacological processes mediated by glucocorticoids involve tissue- and context-specific regulation of glucocorticoid-responsive gene expression via glucocorticoid receptor (GR). However, the molecular mechanisms underlying such highly coordinated regulation of glucocorticoid actions remain to be studied. We here addressed this issue using atp1a1 and scnn1a, both of which are up-regulated in response to corticosteroids in human embryonic kidney-derived 293 cells, but resistant in liver-derived HepG2 cells. Hexamethylene bisacetamide-inducible protein 1 (HEXIM1) represses gene expression via, at least, two distinct mechanisms, i.e. positive transcription elongation factor b sequestration and direct interaction with GR, and is relatively high in HepG2 cells compared with 293 cells. Given this, we focused on the role of HEXIM1 in transcriptional regulation of these GR target genes. In HepG2 cells, hormone resistance of atp1a1 and scnn1a was diminished by either knockdown of HEXIM1 or overexpression of GR. Such a positive effect of exogenous expression of GR was counteracted by concomitant overexpression of HEXIM1, indicating the balance between GR and HEXIM1 modulates hormonal sensitivity of these genes. In support of this, the hormone-dependent recruitment of RNA polymerase II onto atp1a1 promoter was in parallel with that of GR. Moreover, we revealed that not positive transcription elongation factor b-suppressing activity but direct interaction with GR of HEXIM1 plays a major role in suppression of promoter recruitment of the receptor and subsequent atp1a1 and scnn1a gene activation. Collectively, we may conclude that HEXIM1 may participate in tissue-selective determination of glucocorticoid sensitivity via direct interaction with GR at least in certain gene sets including atp1a1 and scnn1a.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCells, CulturedChlorocebus aethiopsCOS CellsDexamethasoneDrug ResistanceEpithelial Sodium ChannelsGene Expression RegulationGlucocorticoidsHeLa CellsHumansMolecular Sequence DataOrgan SpecificityProtein BindingATP1A1 protein, humanDexamethasoneEpithelial Sodium ChannelsGlucocorticoidsHEXIM1 protein, humanReceptors, GlucocorticoidRNA-Binding ProteinsSCNN1A protein, humanSodium-Potassium-Exchanging ATPaseTranscription Factors

Identifiers

PMID18801933
PMCPMC5419410
OpenAlexW2108895456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.